HOME >> BIOLOGY >> NEWS
Evaluation Of The Two Types Of Cardiac Pacemakers Indicates Only Modest Differences In Value

ctional status and long-term cardiac function.

The researchers did see better long-term cardiac functional status in patients with dual chamber pacemakers, but this observation, they say, demonstrates the complexities inherent in measuring quality of life in the elderly. "While it is clear from our results that dual chamber pacing is associated with long-term improvements in cardiovascular function of over time," said Goldman, "aging and the development or worsening of other diseases may overwhelm the modest improvements in cardiovascular functional class and minimize the long-term effect on generic quality of life."

The pacemakers have traditionally been associated with different advantages. The single chamber ventricular pacemaker is less expensive, easier to implant, and has a longer service life than the dual chamber pacemaker; most important, there often are fewer complications associated with the pacemaker itself. Dual chamber pacemakers, on the other hand, offer the theoretical benefit of mimicking the normal electrical sequence of the heart, pacing the atrium first and the ventricular chamber second.

"The question," said Goldman, "has been whether the benefit of the dual chamber pacemaker in terms of heart function and other complications warrants the extra difficulty in placement, shorter battery life and potential risk of complications for the pacemaker itself, as well as the extra cost. The answer seems to be that in many cases it is not."

The 29-center study, called the Pacemaker Selection in the Elderly Trial, involved patients diagnosed with either sinus node dysfunction, a condition in which the heart beat is not initiated at the appropriate rate, or atrial-ventricular block, in which the heart beat is initiated at the appropriate rate but does not make it through the electrical system. Patients were assessed at three, nine and 18 months after enrollment in the study.
'"/>

Contact: Jennifer O'Brien
jobrien@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
16-Apr-1998


Page: 1 2 3

Related biology news :

1. Penn State Wetlands Project Seeks Scientific Evaluation Criteria
2. Research Team Finds Gene Causing Two Types Of Muscular Dystrophy
3. Cardiac arrest may hinder ability to learn certain tasks
4. Cardiac stress tests may indicate if blockages will recur after angioplasty with stent implant
5. Cardiac surgery patients at higher risk
6. Sudden Cardiac Death May Run In Families
7. New Company Formed Through Licensing Of Cardiac-Hypertrophy Technology From Texas Institutions
8. Cardiac Clinical Trial Studies Use of Antibiotic In Preventing Heart Attack
9. Strategic Placement Of Automated External Defibrillators May Help Save Lives Of People Who Go Into Cardiac Arrest
10. Family Ties To Sudden Cardiac Arrest; Study Finds Risk Goes Up 50 Percent
11. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ca (PRWEB) , ... October 12, 2017 , ... ... the Surgical Wound Market with the addition of its newest module, US Hemostats ... $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
Breaking Biology Technology:
Cached News: